120 related articles for article (PubMed ID: 347464)
1. The clinical assessment of brain failure in the elderly.
McConnachie RW
Pharmacology; 1978; 16 Suppl 1():27-35. PubMed ID: 347464
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy].
Ronge J; Dennler HJ
Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638
[No Abstract] [Full Text] [Related]
3. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
4. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
Hughes JR; Williams JG; Currier RD
J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
[TBL] [Abstract][Full Text] [Related]
5. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
[TBL] [Abstract][Full Text] [Related]
7. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
[TBL] [Abstract][Full Text] [Related]
8. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
Pöthig D; Sauer I; Hansen H; Weidnitzer M
Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
[TBL] [Abstract][Full Text] [Related]
9. Hydergine in senile mental impairment.
Loew DM; Weil C
Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
[TBL] [Abstract][Full Text] [Related]
10. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
Dartigues JF; Père JJ
Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
[TBL] [Abstract][Full Text] [Related]
11. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
Yesavage JA; Hollister LE; Burian E
J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
[TBL] [Abstract][Full Text] [Related]
12. Deapril-ST for senile dementia.
Med Lett Drugs Ther; 1977 Jul; 19(15):61-2. PubMed ID: 327247
[No Abstract] [Full Text] [Related]
13. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
Lazzari R; Passeri M; Chierichetti SM
Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
[TBL] [Abstract][Full Text] [Related]
14. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
15. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Jansen W; Bruckner GW; Jansen P
J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
[No Abstract] [Full Text] [Related]
17. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract].
Gerhardt G; Rogalla K; Jaeger J
Fortschr Med; 1990 Jun; 108(19):384-8. PubMed ID: 2199358
[TBL] [Abstract][Full Text] [Related]
19. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
20. Relieving select symptoms of the elderly.
Nelson JJ
Geriatrics; 1975 Mar; 30(3):133-9, 142. PubMed ID: 803912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
